Orbis Medicines
Latest round
- Series A
Last raised
- Jan 2025
Total raised
- $121M
Investors
- 5
About Orbis Medicines
Based in Copenhagen, Denmark, and founded in 2021 by co-founders Chrisitan Heinis and Sevan Habeshian, Orbis Medicines ApS operates as a provider of macrocycle drug development solutions with a focus on oral alternatives to blockbuster biologic drugs and other therapies. The company provides a drug discovery platform called nGen that explores the macrocycle chemical space to create oral macrocycle candidates (nCycles) for intra- and extracellular targeting. Additionally, the firm offers high-throughput chemical synthesis and large-scale assaying services to support drug development efforts.
Who invested in Orbis Medicines
5 investors across 2 rounds
See all investors in Orbis Medicines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Orbis Medicines
Who invested in Orbis Medicines?
Orbis Medicines has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Orbis Medicines raised?
Orbis Medicines has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Orbis Medicines last raise money?
Orbis Medicines's most recent round on record is a Series A, in Jan 2025.
What does Orbis Medicines do?
Based in Copenhagen, Denmark, and founded in 2021 by co-founders Chrisitan Heinis and Sevan Habeshian, Orbis Medicines ApS operates as a provider of macrocycle drug development solutions with a focus on oral alternatives to blockbuster biologic drugs and other therapies.
Where is Orbis Medicines headquartered?
Orbis Medicines is headquartered in Frederiksberg, Denmark.
Which VCs invest in companies like Orbis Medicines?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Orbis Medicines's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Orbis Medicines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.